This is the authors' abstract. We don't add key points for this paper.
Four new compounds prepared from the ligand 2,3-dipyridyl ketone oxime (L 23 ) with varying Cu(II) salts were synthesised and structurally characterised, {[Cu(L 23 )(L 23 -H)](ClO4)}∞ (1), {[Cu(L 23 )(L 23 -H)](BF4)¼(H2O)}∞ (2), [Cu3(L 23 -H)2(L 23 ′)(NO3)2OH]2(NO3)2(C3H8O)6 (3) and [Cu(L 23 )Cl2]∞ (4). The effects of differing counterions, as well as the rotational conformational versatility of L 23 , were demonstrated by the differing polymeric structures that were observed. Complex 1 and 2 both existed as 1-D polymeric chains with L 23 acting as a pseudo-tetradentate ligand through an oxime–oximato bridge. Complex 1 formed a helical arrangement while 2 formed a chiral chain with both 1 and 2 exhibiting similar chiral packing. Complex 3 formed an unusual inverse–9–metallacrown–3 complex, with one of the L 23 ligands in a zwitterionic form. Complex 4 was present as a simple 1-D meso-helical chain.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Argyle et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: